These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30565019)

  • 1. Workshop on the Italian Pharmacovigilance System in the International Context: Critical Issues and Perspectives.
    Sultana J; Moretti U; Addis A; Caduff P; Capuano A; Kant A; Laporte JR; Lindquist M; Raine J; Sartori D; Trifirò G; Tuccori M; Venegoni M; van Puijenbroek E; Leone R
    Drug Saf; 2019 May; 42(5):683-687. PubMed ID: 30565019
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology.
    Baldo P; Francescon S; Fornasier G
    Int J Clin Pharm; 2018 Aug; 40(4):748-753. PubMed ID: 30094557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [From pharmacovigilance to pharmacoepidemiology and risk coordination].
    Montastruc JL
    Rev Med Interne; 2009 Dec; 30 Suppl 4():S281-90. PubMed ID: 19892443
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacovigilance: Importance, concepts, and processes.
    Kumar A
    Am J Health Syst Pharm; 2017 Apr; 74(8):606-612. PubMed ID: 28235869
    [No Abstract]   [Full Text] [Related]  

  • 5. French pharmacovigilance: Missions, organization and perspectives.
    Vial T
    Therapie; 2016 Apr; 71(2):143-50. PubMed ID: 27080832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse drug reactions reporting in Calabria (Southern Italy) in the four-year period 2011-2014: impact of a regional pharmacovigilance project in light of the new European Legislation.
    Leporini C; Marrazzo G; Mumoli L; Esposito S; Gallelli L; Mangano G; Brancati G; De Francesco EA; Russo E; De Sarro G;
    Expert Opin Drug Saf; 2017 May; 16(5):515-522. PubMed ID: 28395523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Direct reporting by patients of adverse drug reactions in Spain].
    Esther Salgueiro M; Jimeno FJ; Aguirre C; García M; Ordóñez L; Manso G
    Farm Hosp; 2013; 37(1):65-71. PubMed ID: 23461502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. User-driven development of a web-based tool for patient reporting of drug-related harm.
    Plöen M; Wallberg M; Olsson S
    Drug Saf; 2015 Apr; 38(4):359-64. PubMed ID: 25711669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project.
    Raschi E; Poluzzi E; Salvo F; Koci A; Suling M; Antoniazzi S; Perina L; Hazell L; Moretti U; Sturkenboom M; Garbe E; Pariente A; De Ponti F
    Drug Saf; 2016 Jan; 39(1):59-68. PubMed ID: 26446144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Italian monitoring registries: a tool for a safer use of innovative drugs? Data from the national pharmacovigilance system.
    Magro L; Arzenton E; Moretti U; Sottosanti L; Potenza S; Leone R
    Expert Opin Drug Saf; 2016 Dec; 15(sup2):69-75. PubMed ID: 27875920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal detection activity on EudraVigilance data: analysis of the procedure and findings from an Italian Regional Centre for Pharmacovigilance.
    Monaco L; Melis M; Biagi C; Donati M; Sapigni E; Vaccheri A; Motola D
    Expert Opin Drug Saf; 2017 Mar; 16(3):271-275. PubMed ID: 28094583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ongoing challenges in pharmacovigilance.
    Dal Pan GJ
    Drug Saf; 2014 Jan; 37(1):1-8. PubMed ID: 24264884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Campania preventability assessment committee: a focus on the preventability of the contrast media adverse drug reactions.
    Sessa M; Rossi C; Rafaniello C; Mascolo A; Cimmaruta D; Scavone C; Fiorentino S; Grassi E; Reginelli A; Rotondo A; Sportiello L
    Expert Opin Drug Saf; 2016 Dec; 15(sup2):51-59. PubMed ID: 27855534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of monitoring adverse drug reactions in elderly patients: the results of a long-term pharmacovigilance programme.
    Carnovale C; Gentili M; Fortino I; Merlino L; Clementi E; Radice S; ViGer Group
    Expert Opin Drug Saf; 2016; 15(2):131-9. PubMed ID: 26882049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role and strategy of ISoP in global pharmacovigilance.
    Olsson S; Harrison-Woolrych M
    Int J Clin Pharm; 2018 Aug; 40(4):740-743. PubMed ID: 30073610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacovigiance: The spontaneous reporting system in Switzerland].
    Schäublin M
    Ther Umsch; 2015 Dec; 72(11-12):743-8. PubMed ID: 26654819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comment on: "Pharmacovigilance in the Middle East".
    Al-Worafi YM
    Drug Saf; 2014 Aug; 37(8):651-2. PubMed ID: 24985531
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacovigilance in India: Present Scenario and Future Challenges.
    Kalaiselvan V; Srivastava S; Singh A; Gupta SK
    Drug Saf; 2019 Mar; 42(3):339-346. PubMed ID: 30269244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Spontaneous Reporting: Assessing Opportunities to Conduct Routine Pharmacovigilance for Antiretroviral Treatment on an International Scale.
    Rachlis B; Karwa R; Chema C; Pastakia S; Olsson S; Wools-Kaloustian K; Jakait B; Maina M; Yotebieng M; Kumarasamy N; Freeman A; de Rekeneire N; Duda SN; Davies MA; Braitstein P
    Drug Saf; 2016 Oct; 39(10):959-76. PubMed ID: 27282427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance of Drug Safety During Pregnancy: Insight in Current International Activities, Future Intentions and Need for Support of National Pharmacovigilance Centres.
    Kant A; de Vries L; Rolfes L
    Drug Saf; 2019 Jan; 42(1):35-43. PubMed ID: 30284215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.